4//SEC Filing
Millar Kerri-Ann 4
Accession 0001209191-23-011245
CIK 0001645460other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:58 PM ET
Size
5.3 KB
Accession
0001209191-23-011245
Insider Transaction Report
Form 4
Millar Kerri-Ann
CHIEF FINANCIAL OFFICER
Transactions
- Award
Stock Option (right to buy)
2023-02-16+124,000→ 124,000 totalExercise: $3.21Exp: 2033-02-15→ Common Stock (124,000 underlying)
Footnotes (1)
- [F1]This stock option becomes exercisable in eight equal semi-annual installments beginning on August 16, 2023.
Documents
Issuer
Cue Biopharma, Inc.
CIK 0001645460
Entity typeother
Related Parties
1- filerCIK 0001739126
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:58 PM ET
- Size
- 5.3 KB